In Mtb, EF-Tu is a key component of the initial trans-translation step, and trans-translation is considered a valid and promising target for the development of new antibiotic drugs to shorten the duration of TB treatment, such as the first-line TB drug pyrazinamide that inhibits trans-translocation of Mtb [41,42,43]. Here, EEF1A1 is linked to tuberculosis.